Skip to main content

Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence

Buy Article:

$51.00 plus tax (Refund Policy)

ABSTRACT Aims 

To establish the feasibility of conducting a placebo-controlled clinical trial of dexamphetamine replacement therapy for cocaine dependence and to obtain preliminary data. Design 

Double-blind randomized placebo-controlled trial. Participants 

Thirty cocaine-dependent injecting drug users. Intervention 

Subjects were assigned randomly to receive 60 mg/day dexamphetamine (n = 16) or placebo (n = 14) for 14 weeks. Measurements 

Immunoassay and mass spectrometric techniques were used to identify cocaine metabolites in urine. Subjects were screened using the Composite International Diagnostic Interview and DSM-IV. The Opiate Treatment Index, Brief Symptom Inventory, Severity of Dependence Scale and visual analogue craving scales were used to collect pre- and post-self-report data. Findings 

Treatment retention was equivalent between groups; however, outcomes favoured the treatment group with no improvements observed in the placebo control group. The proportion of cocaine-positive urine samples detected in the treatment group declined from 94% to 56% compared to no change in the placebo group (79% positive). While the improvements were not significant between groups, within-group analysis revealed that the treatment group reduced self-reported cocaine use (P = 0.02), reduced criminal activity (P = 0.04), reduced cravings (P < 0.01) and reduced severity of cocaine dependence (P < 0.01) with no within-group improvements found in the placebo group. Conclusions 

A definitive evaluation of the utility of dexamphetamine in the management of cocaine dependence is feasible and warranted.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: Cocaine dependence, dexamphetamine, randomized controlled trial, treatment

Document Type: Research Article

Affiliations: 1: National Drug and Alcohol Research Centre, University of New South Wales, 2: St Vincent's Hospital, 3: Kirketon Road Centre, Sydney Hospital 4: and Pacific Laboratory Medicine Services, Sydney, Australia4

Publication date: 2003-08-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more